Hobbs Group Advisors LLC Buys Shares of 661 iShares Biotechnology ETF (NASDAQ:IBB)

Hobbs Group Advisors LLC bought a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 661 shares of the financial services provider’s stock, valued at approximately $91,000.

Other institutional investors have also added to or reduced their stakes in the company. First Horizon Advisors Inc. grew its position in shares of iShares Biotechnology ETF by 5.5% in the 4th quarter. First Horizon Advisors Inc. now owns 2,193 shares of the financial services provider’s stock worth $298,000 after buying an additional 115 shares during the last quarter. Pinnacle Wealth Management Advisory Group LLC grew its position in shares of iShares Biotechnology ETF by 8.3% in the 4th quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,931 shares of the financial services provider’s stock worth $262,000 after buying an additional 148 shares during the last quarter. Corient Private Wealth LLC grew its position in shares of iShares Biotechnology ETF by 1.0% in the 4th quarter. Corient Private Wealth LLC now owns 86,700 shares of the financial services provider’s stock worth $11,778,000 after buying an additional 841 shares during the last quarter. Great Valley Advisor Group Inc. grew its position in shares of iShares Biotechnology ETF by 14.1% in the 4th quarter. Great Valley Advisor Group Inc. now owns 2,786 shares of the financial services provider’s stock worth $378,000 after buying an additional 344 shares during the last quarter. Finally, Mmbg Investment Advisors CO. grew its position in shares of iShares Biotechnology ETF by 0.6% in the 4th quarter. Mmbg Investment Advisors CO. now owns 78,550 shares of the financial services provider’s stock worth $10,671,000 after buying an additional 495 shares during the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.3 %

Shares of iShares Biotechnology ETF stock traded down $0.42 on Tuesday, reaching $147.38. The stock had a trading volume of 1,000,364 shares, compared to its average volume of 1,585,395. The company has a 50 day moving average price of $141.14 and a 200 day moving average price of $136.77. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $150.17.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.